Search

everythinglearnresearchcommunity

for

Search:↓

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

CCCA affects Black men too, with a genetic link found in the PADI3 gene.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Enlarged sweat gland ducts may indicate scarring hair loss.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Hair transplantation can effectively restore hair in patients with stable lichen planopilaris or frontal fibrosing alopecia.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.